Company Market Research Report: Sonara Health, Inc.

Company Overview

Name: Sonara Health, Inc.

Mission: Sonara aims to remove treatment barriers so that people with opioid dependency can live the life they desire while making methadone treatment more convenient and accessible for those with opioid use disorder.

Founded: 2020 by Dr. Michael Giles

Key People:

• Dr. Michael Giles, CEO

• Justin Geller, Chief Operating Officer

• Phil Beck, VP of Growth

• Phoebe Goldenberg, Lead Product Designer

• Neal Ehardt, Lead Software Engineer

• Sheeba Ibidunni, VP of Operations

Headquarters: No information is available.

Number of Employees: No information is available.

Revenue: No information is available.

Known For: Sonara Health is known for its digital solutions that facilitate remote methadone dosing for patients with opioid use disorder, thus enhancing treatment adherence and accessibility.

Products

Sonara Health provides several innovative digital tools primarily aimed at improving the accessibility and efficacy of methadone treatment for opioid use disorder:

1. Tamper-Aware Medication Adherence System:

• Description: A patented system designed to fit all standardized liquid methadone bottles.

• Key Features: Does not obscure labeling requirements; enhances the security and ease of use during medication consumption.

2. Virtual Dosing Window™:

• Description: Allows patients to record themselves taking their methadone dose as scheduled by their care team.

• Key Features: Videos are securely stored in a HIPAA-compliant repository for clinician review, supporting legal compliance and patient accountability.

3. Patient Mobile Application:

• Description: Web-based application designed to engage patients in their treatment without requiring app downloads.

• Key Features: ADA-compliant, optimizes for low-end devices, supports low bandwidth operation, and is designed for usability at a 2nd-grade reading level.

4. Adherence Center:

• Description: A tool for clinicians to monitor and manage patient methadone adherence and treatment plans.

• Key Features: Provides real-time patient data and insights, facilitating informed clinical decisions and improving care quality.

Recent Developments

• Innovations and Grants:

• Received a $2.5M grant from the National Institute on Drug Abuse (NIDA) for advancing the Remote Observed Methadone Evaluation (ROME) study.

• Granted a U.S. patent for its methadone take-home monitoring system, highlighting innovation in ensuring methadone treatment safety and adherence.

• Partnerships:

• New partnership with CareSource expanding service reach to Ohio's BayMark clinics.

• Collaboration with SEARHC in Alaska, Behavioral Health Group in South Carolina, and Central Florida Treatment Center, showing geographic and service expansion.

• Geographic Expansion:

• Expanded remote dosing solutions to nine states, including New Jersey, Ohio, Florida, Alaska, Oregon, California, Oklahoma, South Carolina, and Illinois.

• New Initiatives:

• Pilot programs in New Jersey funded by state budget allocations, aiming to integrate remote methadone dosing into standard Medicaid-covered practices.

• Aimed partnerships with eight to ten local opioid treatment programs in New Jersey planned for 2025.

• Technology Deployment:

• Installation of their technology at addiction recovery clinics, allowing patients to take home methadone with virtual check-ins.

Conclusion

Sonara Health is pioneering in the digital health space for opioid use disorder treatment, focusing on making methadone treatment more accessible and less stigmatizing while ensuring compliance and patient satisfaction. Current developments suggest an expanding presence in multiple states with strategic partnerships and innovative technology solutions that promise to transform opioid addiction treatment protocols.